Exploration of commercial cyclen-based chelators for mercury-197 m/g incorporation into theranostic radiopharmaceuticals

Overview of attention for article published in Frontiers in Chemistry, February 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 5,400 followers.

RT @parmissaran: I'm very excited to share our work published in @FrontiersIn on Exploration of commercial cyclen-based chelators for mercu…

RT @parmissaran: I'm very excited to share our work published in @FrontiersIn on Exploration of commercial cyclen-based chelators for mercu…

RT @parmissaran: I'm very excited to share our work published in @FrontiersIn on Exploration of commercial cyclen-based chelators for mercu…

RT @parmissaran: I'm very excited to share our work published in @FrontiersIn on Exploration of commercial cyclen-based chelators for mercu…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.